Incidence and risk factors for first and recurrent ICD shock therapy in patients with an implantable cardioverter defibrillator
One in eight ICD recipients received appropriate shock 2-7 years after guideline-directed implantation. More than one-third of patients with a first shock experienced recurrent shock. Few clinical variables showed potential in predicting shocks, illustrating a need for more advanced tools to select candidates for implantation.
Authors
- Søren Zöga Diederichsen (ORCID: https://orcid.org/0000-0002-9687-0857)
- Diana My Frodi (ORCID: https://orcid.org/0000-0001-7074-5575)
- Lucas Yixi Xing (ORCID: https://orcid.org/0000-0003-0184-3125)
- Jesper Hastrup Svendsen (ORCID: https://orcid.org/0000-0001-8466-8515)
- Niels Risum (ORCID: https://orcid.org/0000-0002-0357-9164)
- Peter Karl Jacobsen (ORCID: https://orcid.org/0000-0002-1520-8774)
- Daniel Camillo Spona (ORCID: https://orcid.org/0009-0000-2379-6732)
Institutions
- University of Copenhagen (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Journal of Interventional Cardiac Electrophysiology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1007/s10840-024-01873-0
- Citations
- 7
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 2.81
Funders
- Rigshospitalet
- Eurostars